{"id":44089,"date":"2022-05-18T21:01:07","date_gmt":"2022-05-18T19:01:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/"},"modified":"2022-05-18T21:01:07","modified_gmt":"2022-05-18T19:01:07","slug":"neuro42-licenses-robot-from-johns-hopkins-university","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/","title":{"rendered":"neuro42 Licenses Robot from Johns Hopkins University"},"content":{"rendered":"
\n

SAN FRANCISCO–(BUSINESS WIRE)–neuro42, Inc.<\/a> (\u201cneuro42\u201d or the \u201cCompany\u201d), a medical imaging, robotics, and AI technology company, today announced an exclusive licensing agreement with Johns Hopkins University (\u201cJohns Hopkins\u201d) for their MR compatible robot for head, neck and spine applications, with additional non-exclusive licenses for related technologies and patents. Developed by Dr. Dan Stoianovici, director of the Urology Robotics Program at the Brady Urological Institute and a professor of neurosurgery at the Johns Hopkins University School of Medicine, the robot provides targeted needle insertion with precision depth control. It is designed with nonmagnetic and nonconductive materials to be compatible with magnetic resonance imagers.\n<\/p>\n

<\/a><\/p>\n

\n\u201cThe novel architecture of our imaging system will incorporate the robot to facilitate image-guided interventions during brain biopsies, shunt placements and laser ablations, giving neurosurgeons a more practical intraoperative solution for such procedures than a traditional MRI. We look forward to collaborating with the team at Johns Hopkins to enable safe and effective intraoperative MR treatments using the neuro42 scanner and the robot,\u201d said Abhita<\/a> Batra, Co-founder and Chief Strategy Officer of neuro42.\n<\/p>\n

\nAbout neuro42, Inc.<\/b>\n<\/p>\n

\nneuro42, Inc. is a San Francisco, CA based medical technology company focused on diagnostic imaging and image guided surgical interventions of the brain. Founded by a team of successful entrepreneurs and healthcare innovators, the Company is developing and commercializing an intraoperative MR, AI and robotic system that allows easy access to MR imaging for screening, diagnosis and interventions of neurological diseases. Backed by over 30 patents, neuro42\u2019s platform is poised to enhance patient and physician experience with its novel, easy-to-use and portable configuration.\n<\/p>\n

\nTo learn more about the company and its technology, visit neuro42.ai.\n<\/p>\n

\nLinkedIn: neuro42
\n
Twitter: neuro42
\n
Facebook: neuro42\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAshley Areeda
\n
Jive PR + Digital
\n
aareeda@jiveprdigital.com<\/a>
m: 734.891.4013\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN FRANCISCO–(BUSINESS WIRE)–neuro42, Inc. (\u201cneuro42\u201d or the \u201cCompany\u201d), a medical imaging, robotics, and AI technology company, today announced an exclusive licensing agreement with Johns Hopkins University (\u201cJohns Hopkins\u201d) for their MR compatible robot for head, neck and spine applications, with additional non-exclusive licenses for related technologies and patents. Developed by Dr. Dan Stoianovici, director of … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44089","6":"format-standard","7":"category-industry"},"yoast_head":"\nneuro42 Licenses Robot from Johns Hopkins University - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"neuro42 Licenses Robot from Johns Hopkins University - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO–(BUSINESS WIRE)–neuro42, Inc. (\u201cneuro42\u201d or the \u201cCompany\u201d), a medical imaging, robotics, and AI technology company, today announced an exclusive licensing agreement with Johns Hopkins University (\u201cJohns Hopkins\u201d) for their MR compatible robot for head, neck and spine applications, with additional non-exclusive licenses for related technologies and patents. Developed by Dr. Dan Stoianovici, director of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-18T19:01:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220518006046\/en\/1460484\/21\/2-1-Dark_BG.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuro42-licenses-robot-from-johns-hopkins-university\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuro42-licenses-robot-from-johns-hopkins-university\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"neuro42 Licenses Robot from Johns Hopkins University\",\"datePublished\":\"2022-05-18T19:01:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuro42-licenses-robot-from-johns-hopkins-university\\\/\"},\"wordCount\":298,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuro42-licenses-robot-from-johns-hopkins-university\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518006046\\\/en\\\/1460484\\\/21\\\/2-1-Dark_BG.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuro42-licenses-robot-from-johns-hopkins-university\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuro42-licenses-robot-from-johns-hopkins-university\\\/\",\"name\":\"neuro42 Licenses Robot from Johns Hopkins University - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuro42-licenses-robot-from-johns-hopkins-university\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuro42-licenses-robot-from-johns-hopkins-university\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518006046\\\/en\\\/1460484\\\/21\\\/2-1-Dark_BG.jpg\",\"datePublished\":\"2022-05-18T19:01:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuro42-licenses-robot-from-johns-hopkins-university\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuro42-licenses-robot-from-johns-hopkins-university\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuro42-licenses-robot-from-johns-hopkins-university\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518006046\\\/en\\\/1460484\\\/21\\\/2-1-Dark_BG.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518006046\\\/en\\\/1460484\\\/21\\\/2-1-Dark_BG.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuro42-licenses-robot-from-johns-hopkins-university\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"neuro42 Licenses Robot from Johns Hopkins University\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"neuro42 Licenses Robot from Johns Hopkins University - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/","og_locale":"en_US","og_type":"article","og_title":"neuro42 Licenses Robot from Johns Hopkins University - Pharma Trend","og_description":"SAN FRANCISCO–(BUSINESS WIRE)–neuro42, Inc. (\u201cneuro42\u201d or the \u201cCompany\u201d), a medical imaging, robotics, and AI technology company, today announced an exclusive licensing agreement with Johns Hopkins University (\u201cJohns Hopkins\u201d) for their MR compatible robot for head, neck and spine applications, with additional non-exclusive licenses for related technologies and patents. Developed by Dr. Dan Stoianovici, director of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-18T19:01:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220518006046\/en\/1460484\/21\/2-1-Dark_BG.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"neuro42 Licenses Robot from Johns Hopkins University","datePublished":"2022-05-18T19:01:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/"},"wordCount":298,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220518006046\/en\/1460484\/21\/2-1-Dark_BG.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/","url":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/","name":"neuro42 Licenses Robot from Johns Hopkins University - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220518006046\/en\/1460484\/21\/2-1-Dark_BG.jpg","datePublished":"2022-05-18T19:01:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220518006046\/en\/1460484\/21\/2-1-Dark_BG.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220518006046\/en\/1460484\/21\/2-1-Dark_BG.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"neuro42 Licenses Robot from Johns Hopkins University"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44089"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44089\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}